Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Attention Training Technique and Mindful Self-Compassion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03332381
Recruitment Status : Completed
First Posted : November 6, 2017
Last Update Posted : November 6, 2017
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:
The design of the study is a randomized controlled trial. A total of 80 students with self-reported symptoms of stress/anxiety/depression will be invited to take part in a 3-session course consisting of either attention training or self-compassion/mindfulness based meditation. Attention training involves modifying metacognitive control and enhancing attention flexibility so that people can refrain from responding to intrusions with extended processing. Self-compassion involves not avoiding painful or distressing feelings. Instead these experiences are held in awareness with kindness, understanding, and a sense of shared humanity.

Condition or disease Intervention/treatment Phase
Anxiety Depression Stress, Psychological Behavioral: Attention training technique Behavioral: Mindful self-compassion Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 81 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: RCT
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial Comparing the Attention Training Technique and Mindful Self-Compassion
Actual Study Start Date : May 1, 2015
Actual Primary Completion Date : May 1, 2017
Actual Study Completion Date : September 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Active Comparator: Attention training technique Behavioral: Attention training technique
Attention training involves modifying metacognitive control and enhancing attention flexibility so that people can refrain from responding to intrusions with extended processing.
Other Name: ATT

Active Comparator: Mindful self-compassion Behavioral: Mindful self-compassion
Self-compassion involves not avoiding painful or distressing feelings. Instead these experiences are held in awareness with kindness, understanding, and a sense of shared humanity.
Other Name: MSC




Primary Outcome Measures :
  1. Change in symptoms of depression as assessed with the Patient Health Questionnaire-9 [ Time Frame: Baseline, immediately after last session, 6 months after intervention ]
    Assesses symptoms of depression. Total score range from 0 (no depression) to 27 (very depressed). Lower values represent better outcome. Subscale scores are not used.

  2. Change in symptoms of anxiety as assessed with the Generalized Anxiety Disorder-7 scale [ Time Frame: Baseline, immediately after last session, 6 months after intervention ]
    Assesses symptoms of anxiety. Total score range from 0 (no depression) to 21 (very depressed). Lower values represent better outcome. Subscale scores are not used.


Secondary Outcome Measures :
  1. Changes in self-compassion as assessed by the Self-Compassion Scale Short Form [ Time Frame: Baseline, immediately after last session, 6 months after intervention ]
    Assessment of self-compassion. Total score range from 12 (no self-compassion) to 60 (high on self-compassion). Higher values represent better outcome. Subscale scores are not used.

  2. Changes in the attention flexibility subscale of the Detached Mindfulness Questionnaire [ Time Frame: Baseline, immediately after last session, 6 months after intervention ]
    Assessment of attention flexibility. Total score for attention flexibility range from 5 (no flexibility) to 25 (very flexible). Higher values represent better outcome. No other subscales are used.

  3. Changes in mindfulness as assessed with The Five Facet Mindfulness Questionnaire [ Time Frame: Baseline, immediately after last session, 6 months after intervention ]
    Assessment of mindfulness. Total score range from 20 (not mindful at all) to 100(very mindful). Higher values represent better outcome. Subscale scores are not analyzed.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • self reported symptoms of stress/anxiety/depression

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03332381


Locations
Layout table for location information
Norway
Psykologisk Institutt, Dragvoll
Trondheim, Norway, 7491
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Layout table for investigator information
Study Director: Magne Flaten, phd Norwegian University of Science and Technology

Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT03332381     History of Changes
Other Study ID Numbers: 2015/470-1
First Posted: November 6, 2017    Key Record Dates
Last Update Posted: November 6, 2017
Last Verified: November 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Stress, Psychological
Behavioral Symptoms